Patients with MEN2A show a high penetrance for medullary thyroid carcinoma (MTC) or C-cell hyperplasia (nearly 100%), PCC (50%), and multiglandular parathyroid hyperplasia or adenoma (20–30%), leading to primary hyperparathyroidism (Wells et al. 2015). The gene discussed is RET; the disease is primary hyperparathyroidism.